#ThinkSabio Latest News
MBRX – Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models – Data Presented at AACR 2026
MBRX – Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models – Data Presented at AACR 2026